Drugs / MT-0814
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03869684 | Feb 2019 → Mar 2020 | age-related macular degeneration | Senju Pharmaceutical Co., Ltd. | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MT-0814 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03869684 ↗ |